FDA Denies Accelerated Approval for ALS Drug FDA Denies Accelerated Approval for ALS Drug

The FDA has rejected Clene Nanomedicine ' s application for accelerated approval for the experimental drug ALS drug, CNM-Au8, citing insufficient evidence.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery Source Type: news